TwinToken’s primary objective is to entrench TwinPharma as a web- and mobile application that delivers convenience and self-medication options to the S.A. consumer.
As a medium of exchange, TwinToken will seek implement a utility mechanism to (inevitably) function as a medium of exchange between patients and:
- Both private and public healthcare providers,
- Digital pharmaceutical distribution agents,
- Healthcare data collection agents,
- Fitness and other wearable tech vendors, etc.
TwinToken is denoted by the symbol “XTW”, and its etherscan details can be found here:
https://etherscan.io/token/0x037eb59665afccd8a9c09a16621a13e51064da9f
The TwinPharma retail pharmaceutical application began conceptual design and alpha testing back in late 2016 and into 2017. Based on the success of these initial tests and prototype acceptance from interested players in the pharmaceutical industry, XTW was added as a utility token payment mechanism, and the team proceeded to a private ICO to raise seed funding for all the application and accelerate development to beta testing phase.
The historic timeline and outline for the for the next three years, following the Public ICO, is as follows:
TwinToken will function as an ERC-20 token standardised on the Ethereum blockhain,
TWINTOKEN is denoted by the SYMBOL (XTW)
TwinToken will be managed through exacting standards of governance with a full Board of Directors, Investment Committee, Ethics Committee, and will present annual audited financial statements and an annual report.
XTW is listed and tradeable on an approved exchange. Please visit https://www.stex.com
